Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa

被引:87
作者
Kim, Jong Hoon [1 ,2 ]
Kim, Soo-Chan [1 ,2 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Dermatol, Seoul, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
paraneoplastic pemphigus; neoplasms; tolerance; humoral immunity; cell-mediated immunity; LYMPHOCYTIC-LEUKEMIA; MULTIORGAN SYNDROME; DESMOGLEIN; 3; BRONCHIOLITIS OBLITERANS; IMMUNOLOGICAL FEATURES; UP-REGULATION; T-CELLS; IN-VIVO; B-CELLS; EXPRESSION;
D O I
10.3389/fimmu.2019.01259
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Paraneoplastic pemphigus (PNP) is a rare but life-threatening mucocutaneous disease mediated by paraneoplastic autoimmunity. Various neoplasms are associated with PNP. Intractable stomatitis and polymorphous cutaneous eruptions, including blisters and lichenoid dermatitis, are characteristic clinical features caused by humoral and cell-mediated autoimmune reactions. Autoreactive T cells and IgG autoantibodies against heterogeneous antigens, including plakin family proteins and desmosomal cadherins, contribute to the pathogenesis of PNP. Several mechanisms of autoimmunity may be at play in this disease on the type of neoplasm present. Diagnosis can be made based on clinical and histopathological features, the presence of anti-plakin autoantibodies, and underlying neoplasms. Immunosuppressive agents and biologics including rituximab have been used for the treatment of PNP; however, the prognosis is poor due to underlying malignancies, severe infections during immunosuppressive treatment, and bronchiolitis obliterans mediated by autoimmunity. In this review, we overview the characteristics of PNP and focus on the immunopathology and the potential pathomechanisms of this disease.
引用
收藏
页数:11
相关论文
共 116 条
[1]   An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains [J].
Aaltonen, J ;
Bjorses, P ;
Perheentupa, J ;
HorelliKuitunen, N ;
Palotie, A ;
Peltonen, L ;
Lee, YS ;
Francis, F ;
Hennig, S ;
Thiel, C ;
Lehrach, H ;
Yaspo, ML .
NATURE GENETICS, 1997, 17 (04) :399-403
[2]   Antibodies against desmoglein 3 (Pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice [J].
Amagai, M ;
Nishikawa, T ;
Nousari, HC ;
Anhalt, GJ ;
Hashimoto, T .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :775-782
[3]   Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus [J].
Amber, Kyle T. ;
Valdebran, Manuel ;
Grandoa, Sergei A. .
AUTOIMMUNITY REVIEWS, 2018, 17 (10) :1002-1010
[4]   AIRE expands: new roles in immune tolerance and beyond [J].
Anderson, Mark S. ;
Su, Maureen A. .
NATURE REVIEWS IMMUNOLOGY, 2016, 16 (04) :247-258
[5]   Paraneoplastic pemphigus [J].
Anhalt, GJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (01) :29-33
[6]   PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA [J].
ANHALT, GJ ;
KIM, S ;
STANLEY, JR ;
KORMAN, NJ ;
JABS, DA ;
KORY, M ;
IZUMI, H ;
RATRIE, H ;
MUTASIM, D ;
ARISSABDO, L ;
LABIB, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1729-1735
[7]   Paraneoplastic pemphigus regression after thymoma resection [J].
Barbetakis, Nikolaos ;
Samanidis, Georgios ;
Paliouras, Dimitrios ;
Boukovinas, Ioannis ;
Asteriou, Christos ;
Stergiou, Eleni ;
Laschos, Kostas ;
Tsilikas, Christodoulos .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
[8]   Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus [J].
Bech, R. ;
Baumgartner-Nielsen, J. ;
Peterslund, N. A. ;
Steiniche, T. ;
Deleuran, M. ;
d'Amore, F. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (02) :469-472
[9]   Delayed detection of autoantibodies in paraneoplastic pemphigus [J].
Bennett, Daniel D. ;
Busick, Tommy L. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (06) :1094-1095
[10]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238